CRDF
Price
$2.08
Change
+$0.02 (+0.97%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
137.04M
31 days until earnings call
MRVI
Price
$2.84
Change
+$0.02 (+0.71%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
407.99M
37 days until earnings call
Interact to see
Advertisement

CRDF vs MRVI

Header iconCRDF vs MRVI Comparison
Open Charts CRDF vs MRVIBanner chart's image
Cardiff Oncology
Price$2.08
Change+$0.02 (+0.97%)
Volume$900
Capitalization137.04M
Maravai LifeSciences Holdings
Price$2.84
Change+$0.02 (+0.71%)
Volume$35.3K
Capitalization407.99M
CRDF vs MRVI Comparison Chart in %
Loading...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDF vs. MRVI commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Buy and MRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 30, 2025
Stock price -- (CRDF: $2.06 vs. MRVI: $2.82)
Brand notoriety: CRDF and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 31% vs. MRVI: 73%
Market capitalization -- CRDF: $137.04M vs. MRVI: $407.99M
CRDF [@Biotechnology] is valued at $137.04M. MRVI’s [@Biotechnology] market capitalization is $407.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 6 TA indicator(s) are bullish while MRVI’s TA Score has 6 bullish TA indicator(s).

  • CRDF’s TA Score: 6 bullish, 2 bearish.
  • MRVI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CRDF is a better buy in the short-term than MRVI.

Price Growth

CRDF (@Biotechnology) experienced а +0.49% price change this week, while MRVI (@Biotechnology) price change was +4.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.29%. For the same industry, the average monthly price growth was +11.39%, and the average quarterly price growth was +59.66%.

Reported Earning Dates

CRDF is expected to report earnings on Oct 30, 2025.

MRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($408M) has a higher market cap than CRDF($137M). MRVI YTD gains are higher at: -48.257 vs. CRDF (-52.535). CRDF has higher annual earnings (EBITDA): -53.95M vs. MRVI (-247.68M). MRVI has more cash in the bank: 270M vs. CRDF (71M). CRDF has less debt than MRVI: CRDF (1.19M) vs MRVI (364M). MRVI has higher revenues than CRDF: MRVI (220M) vs CRDF (545K).
CRDFMRVICRDF / MRVI
Capitalization137M408M34%
EBITDA-53.95M-247.68M22%
Gain YTD-52.535-48.257109%
P/E RatioN/AN/A-
Revenue545K220M0%
Total Cash71M270M26%
Total Debt1.19M364M0%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRDFMRVI
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RELV2.52N/A
N/A
Reliv International, Inc.
QUCOF9.00N/A
N/A
Qualitas Controladora SAB De CV
HLFN33.50N/A
N/A
Home Loan Financial Corp.
HKHHY33.80-0.09
-0.27%
Heineken Holding N.V.
PMETF3.00-0.02
-0.63%
PMET Resources Inc.

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with MRVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then MRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
+0.98%
MRVI - CRDF
44%
Loosely correlated
+4.83%
NAMS - CRDF
41%
Loosely correlated
+8.41%
ORMP - CRDF
39%
Loosely correlated
+0.42%
NRIX - CRDF
38%
Loosely correlated
+7.20%
ABSI - CRDF
38%
Loosely correlated
+3.02%
More